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P2X purinergic receptors are plasmamembrane ATP-dependent cation channels that are
broadly distributed in the mammalian tissues. P2RX2 is a modulator of auditory sensory
hair cell mechanotransduction and plays an important role in hair cell tolerance to noise.
In this study, we demonstrate for the first time in vitro and in cochlear neuroepithelium,
that P2RX2 possesses the ATPase activity. We observed that the P2RX2 V60L human
deafness mutation alters its ability to bind ATP, while the G353R has no effect on ATP
binding or hydrolysis. A non-hydrolysable ATP assay using HEK293 cells suggests that
ATP hydrolysis plays a significant role in the opening and gating of the P2RX2 ion channel.
Moreover, the results of structural modeling of the molecule was in agreement with our
experimental observations. These novel findings suggest the intrinsic ATPase activity of
P2RX2 and provide molecular insights into the channel opening.
Keywords: P2X2, ATPase activity, Ligand-gated ion channels, Electrophysiology, computer modeling
INTRODUCTION
P2X receptor family comprises seven different receptors, P2RX1 to P2RX7 (Mittal et al.,
2016). These receptors are expressed in a wide variety of cell types and are involved in
numerous physiological processes, including platelet aggregation, immune responses smooth
muscle contraction, inflammation, and sensory neurotransmission (Burnstock, 2013; Zhang et al.,
2015; Martínez-Ramírez et al., 2016; Riding and Pullar, 2016; Sáez-Orellana et al., 2016). Out of
these seven receptors, P2RX2 is an ATP-gated trimeric ion channel that plays an important role
in sound transduction and auditory neurotransmission in the inner ear (Housley et al., 2002, 2013;
Järlebark et al., 2002;Wang et al., 2003; Yan et al., 2013). ATP binding to the extracellular loop of the
channel is thought to cause conformational changes that trigger channel pore opening and cation
internalization (North, 2002; Roberts et al., 2006; Stelmashenko et al., 2012; Mittal et al., 2016;
Wang and Yu, 2016). However, it is not known whether ATP binding or hydrolysis is required for
the P2X2 activation.
Ion channels including ATP-gated P2RX2 channels have been demonstrated to be regulated
by phosphoinositides (PIP ns) (Hille et al., 2015). PIP ns are minor phospholipids that comprises
less than 1% of total membrane lipids, but play a very crucial role in cell signaling events (Viaud
et al., 2015; Waugh, 2015; Marat and Haucke, 2016). PIP ns are involved in the activation of
many ion channels and enzymes, and regulate virtually all membrane trafficking events, including
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endocytosis and exocytosis (Swanson, 2014; Levin et al., 2015;
Posor et al., 2015). PIP ns also recruit proteins to the
plasmamembrane or intracellular compartments through several
structured interaction domains (Balla, 2013; Cauvin and Echard,
2015). The pharmacological depletion of PIP ns with the PI3K
blockers wortmannin and LY294002 has been demonstrated to
affect P2RX2 channel gating (Fujiwara and Kubo, 2006). The
lack of PIP ns accelerated P2RX2 channel desensitization that
was also observed with two mutations, K365Q or K369Q in
the conserved, positively charged, amino acid residues in the
proximal region of the cytoplasmic C-terminal domain. These
findings suggest that the interaction between lysine residues
at positions 365 and 369 with PIP ns play an important role
in stabilizing the open conformation of the P2X2 channel. It
was demonstrated that P2X2 pore dilation is closely linked
to channel desensitization and is regulated by the binding of
PIP ns to the cytoplasmic C-terminal region of the channel by
determining the time-dependent permeability shift in N-methyl-
D-glucamine (NMDG+)- (Fujiwara and Kubo, 2006). GST-
tagged recombinant proteins spanning the proximal C-terminal
region of P2RX2 were able to directly bind to PIP ns. EGFP
tagged fusion proteins comprising the proximal C-terminal
region of P2X2 expressed in COS-7 cells closely associated to the
membrane PIP ns. These results suggest that PIP ns play a key role
in regulating P2X2 channel activity and pore dilation.
To understand the molecular mechanisms underlying
opening and closing of P2RX2 through ATP binding, different
amino acids have been mutated using site-directed mutagenesis
in purified rat P2RX2 (rP2RX2) or human P2RX2 (hP2RX2)
(Chataigneau et al., 2013; Jiang et al., 2013; Dal Ben et al.,
2015; Habermacher et al., 2016). Mutations namely, F183C,
T184C, and F289C causes 4–10-fold decrease in ATP binding
to hP2X2 (Roberts et al., 2008; Chataigneau et al., 2013). The
mutations N288C, R290C, and K307C have also been implicated
in decreased binding of ATP to hP2X2 (Roberts et al., 2008;
Chataigneau et al., 2013). Mutations K69C, and K71C leads to
non-functional hP2X2 that is unable to bind ATP (Roberts et al.,
2008; Chataigneau et al., 2013). It has been demonstrated that
two residues N140 and L186 play a crucial role in ATP binding to
rP2X2 using a thiol-reactive probe (8-thiocyano-ATP, NCS-ATP)
(Jiang et al., 2011).
Some of the mutations in cation channels including P2X2
have clinical implications and have been associated with hearing
loss in humans. Hearing loss is the most common sensory
deficit in human populations causing significant deterioration
in the quality of life (Géléoc and Holt, 2014). About 50–60%
of hearing loss cases have a genetic etiology (Ouyang et al.,
2009; Angeli et al., 2012; Bogo et al., 2015; Chakchouk et al.,
2015; Grati et al., 2015; Parker and Bitner-Glindzicz, 2015;
Qing et al., 2015; Wang et al., 2015; Yan et al., 2015). The
remaining 40–50% of cases are attributed to environmental
factors such as ototoxic drugs, prematurity, or trauma (Roizen,
1999; Furness, 2015;Momi et al., 2015). However, as public health
awareness is improved, environmental factors are contributing
less to the etiology of deafness and the relative proportion of
genetic hearing loss is increasing. Approximately, one in every
1,000 children has some form of prelingual hearing impairment,
and one in 2000 is caused by a genetic mutation (Vele and
Schrijver, 2008). About 30% of cases of prelingual deafness are
classified as syndromic; the remainder cases are nonsyndromic
(Stelma and Bhutta, 2014). We and others have demonstrated
that V60L and G353R mutations in P2RX2 cause dominant
progressive hearing loss in humans (Yan et al., 2013; Faletra
et al., 2014). Since these mutations cause deafness and have
significant clinical implications, it is worthwhile to examine how
these mutations affect the physiological function of P2RX2 cation
channel. Understanding the mechanisms through which these
mutations affect the normal function and activation of P2RX2
will help in designing novel treatment modalities against hearing
loss. Intriguingly, we observed that ATP binding as well as its
hydrolysis is an essential step for the hP2RX2 activation. The
mutation, V60L, in this cation channel hampers the ability of
hP2RX2 for ATP hydrolysis and subsequent activation.
MATERIALS AND METHODS
Purification of Proteins
Wild-type (WT) and mutant forms of human P2RX2 (hP2RX2)
were obtained from Origene (Rockville, MD). Briefly,
recombinant proteins were overexpressed in HEK293 cells
and then purified using anti-DDK affinity column followed by
conventional chromatography steps. The purity of proteins was
examined by Coomassie staining. Western blotting was also used
to confirm the purity of the proteins employing P2RX2 antibody
(Abcam, Cambridge, MA).
Patch-Clamp Analysis of ATP-Evoked
Currents
HEK293 cells were cultured in DMEM with 10% fetal bovine
serum (FBS) and 100 U/mL penicillin at 37 ◦C in a 5% CO2
incubator. At 90% confluence, cells were passed by trypsin-
EDTA, reseeded at a 24-well plate with a density of 100,000
cells per well and incubated overnight. The medium was
then replaced with the fresh DMEM plus 10% FBS and a
transfection reaction mixture containing OPTI-MEM medium,
Lipofectamine 2000, and the P2RX2 plasmid (WT or mutant
forms). After 24–48 h, successful transfectants were identified
under fluorescent microscopy. Cells were then trypsinized and
replated with normal extracellular solution (130 mM NaCl,
5mM KCl, 1.47mM MgCl2, 2mM CaCl2, 25 mM dextrose,
and 10 mM Hepes; 300 mOsm, pH 7.2) in 35-mm culture
dishes for whole-cell patch clamp recordings. Single, isolated
transfected HEK293 cells with strong fluorescence were selected,
and whole-cell recording was performed. Cells were placed in
a recording chamber containing extracellular solution of the
following composition (in mM): 140 NaCl, 10 HEPES, 1 MgCl2,
2 CaCl2, 10 glucose (pH 7.4,∼315 mOsm) and visually identified
using a 60× objective (0.9 numerical aperture) (Olympus) and
infrared differential interference contrast. Recording electrodes
(2.5–4 M) were pulled from thick-walled borosilicate glass
(Sutter Instruments) and filled with intracellular solution that
contained (in mM): 140 CsCl, 10 HEPES, 1 MgCl, 5 EGTA
(pH 7.3, ∼295 mOsm). Data were filtered at 10 kHz using a
Multi-clamp 700B amplifier (Molecular Devices) and sampled
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at 10 kHz. Series resistance (5–12 M) was compensated by
70–80%. Responses were evoked by local puff application via
a glass patch-clamp pipette connected to a Picospritzer (Parker
Hannifin, Pine Brook, NJ). All data were acquired and analyzed
using custom routines written in IgorPro (WaveMetrics). In
some experiments we used hydrolysable ATP, non-hydrolysable
ATP [adenosine 5′-(β,γ-imido) triphosphate tetralithium salt
hydrate, AMP-PNP] or ADP in the concentration range of 36µM
to 1mM as described in earlier studies (Li et al., 2013; Yan et al.,
2013) and recorded current responses.
ATpase, ADP, and ATP Assays
ATP hydrolysis activity of P2RX2 WT and mutant proteins
were performed based on a BIOMOL Green method (Harder
et al., 1994) (Enzo Life Sciences, Farmingdale, NY). This
colorimetric phosphate quantitation method measures free
phosphate released to solution. Briefly, 2.5 pmol of purified
P2RX2 WT, V60L, G353R, and K81A proteins were incubated
with 1 mM of fresh-made ATP in the presence of either NaCl,
or KCl, or CaCl2 in a MOPS buffer (50 mM MOPS, pH 7.0,
0.1% Triton X-100, 1mM MgCl2, 100 mM indicated salt) for
30min. In some experiments, different concentrations of P2X2
specific inhibitor, RB-4 (Baqi et al., 2011), were also included.
After measuring OD630 of the reaction mixture, determination
of the released phosphate was calculated as described by the
manufacturer (Enzo Life Sciences, Farmingdale, NY). Phosphate
standards were used to calibrate a standard curve and ATP
hydrolysis activity was expressed as nanomol phosphate released
as per manufacturer’s instructions. For determination of ADP
and AMP levels, proteins were incubated with ATP as described
above and then subjected to ADP and AMP assay using kits from
Sigma (St. Louis, MO) as per manufacturer’s instructions.
Filter-Binding Assay
The binding of WT hP2RX2 and its mutant forms to radioactive
ATP was determined by Filter- binding assay as described earlier
(Makise et al., 2003). Briefly, proteins were incubated with [α-
32P] ATP or [3H] AMP-PNP for 30min in protein buffer (25mM
Tris, 100mM KCl, 5mM MgCl2, 1mM DTT, pH 7.6). Samples
were passed through nitrocellulose membranes (Millipore HA,
0.45 µm) and washed with ice cold protein buffer supplemented
with 40mMMgCl2. The radioactivity remaining on the filter was
determined with a liquid scintillation counter.
Rat Inner Ear Explant Cultures and
Transfections
Organs of Corti from inner ears of postnatal day 3 (P3) rats
(of either sex) were dissected (Grati et al., 2006; Salles et al.,
2009) in accordance with National Institutes of Health guidelines
and maintained for 1–2 days in culture. The study protocol was
approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Miami. Explants were used to
examine the endogenous ATPase activity in the absence or
presence of P2RX2 competitive antagonist, RB-4.
FIGURE 1 | P2RX2 p.V60L attenuates ATP evoked inward current.
HEK293 cells were transfected with GFP-tagged WT or mutant
P2RX2-encoding plasmids and were patch-clamp recorded for inward current
following stimulation with ATP (36 µM–1mM). (A) ATP-evoked inward current
is visible in an HEK293 cells expressing WT P2RX2 that is abolished in cells
expressing mutant P2RX2 V60L. Cells expressing mutant P2RX2 p.G353R
show a lower inward current peak than those expressing WT P2RX2. Cells
co-expressing WT and mutant P2RX2 showed attenuated inward current
compared to those expressing only WT P2RX2. (B) The inward rectifying
ATP-gated current across the applied voltage range in an HEK293 cells
expressing WT or mutant P2RX2. The current–voltage (I-V) relationship was
determined as the average current over the last 20ms at the various voltage
steps during the steady-state phase of the ATP-gated inward current.
Whole-cell recording was performed using an Axopatch 200B patch clamp
amplifier (Molecular Devices) and data were analyzed with jClamp. The
experiments were performed three different times in triplicate. Error bars
indicate standard deviations.
Structural Modeling
Structural model of human P2X2 ion channel (residues 41–
365) in closed and open states was built using the MODELER
software based on homology modeling (Martí-Renom et al.,
2000). Briefly, the corresponding crystal structures of the related
zebrafish P2RX4 ion channel in open (PDBID 4DW0) and closed
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(PDBID 4DW1) states were used as templates. It is noteworthy
that the zebrafish and human P2RX channels share close to
50% amino acid sequence identity, implying that the structural
models of the latter can be relied upon with a high degree of
confidence. In each case, a total of 100 atomic models were
calculated and the structure with the lowest energy, as judged
by the MODELER Objective Function, was selected for further
analysis. The structural models were rendered using RIBBONS
(Carson, 1991). The closed and open states were morphed with
the VMD software (Humphrey et al., 1996).
Statistical Analysis
Results were statistically analyzed using one-way ANOVA with a
post hoc test. P < 0.05 was considered statistically significant.
RESULTS
Electrophysiological Recordings
Using patch clamp recording, ATP stimulation (concentration
ranging from 36 µM to 1 mM) of HEK293 cells expressing WT
P2RX2 evoked a large inward current, as did to a lesser intensity
G353R form, but a very faint or no current was obtained with
V60L form (Figures 1A,B).
Purification of Proteins and ATPase Activity
Next, we overexpressed and purified P2RX2 and its mutant
forms in HEK293 cells. We also used in this study P2RX2 K81A
mutant form which has previously proven incapable of binding
ATP (Jiang et al., 2000; Wilkinson et al., 2006). The purity of
the proteins was determined by SDS page, Commassie staining
and Western blotting (Figures S1A,B). Purified proteins were
incubated with ATP and phosphate release was monitored using
Biomol Green reagent (Enzo Life Sciences, PA). As P2RX2 is a
cation channel that regulates the influx of ions including K+,
Na+, and Ca2+, we determined the phosphate release in the
presence of theses ions. P2RX2 was found to actively hydrolyze
ATP and is independent of the presence of K+, Na+, or Ca2+
(Figure 2A). This ATPase activity was significantly inhibited by
P2RX2 competitive antagonist, RB-4, confirming the specificity
of the reaction (Figure 2B). Interestingly, P2RX2 V60L’s ability to
hydrolyze ATP was significantly attenuated compared to WT or
G353R P2RX2 (P < 0.001; Figure 2C). To further confirm these
findings, HEK293 cells were transfected with WT and mutant
forms of P2RX2 and ATP hydrolysis was determined in live
cells.We observed that HEK293 expressing V60L P2RX2 released
significantly less inorganic phosphate (iP) than WT or G353R
P2RX2 (P< 0.001; Figure 2D). Using Michaelis-Menten kinetics
equation, we calculated Km value for ATP and found it to be 0.62
mM, indicating high ATP affinity (Figure 2E). Following first
order reaction kinetics, ATP hydrolysis was linearly proportional
with reaction time (Figure 2F).
Non-Hydrolysable ATP Failed to Evoke
Inward Current Responses
We further performed electrophysiological recordings on
HEK293 cells to investigate the gating properties of WT
P2XR2 ion channels. We locally applied hydrolysable ATP,
non-hydrolysable ATP analog [adenosine 5′-(β,γ-imido)
triphosphate, AMP-PNP] or ADP, ranging in concentration
from 36 µM to 1mM, and recorded current responses. Our
results show that local application of hydrolysable ATP for
100 ms evoked large responses (−4029 ± 931 pA, n = 6
cells) mediated by P2RX2. On the contrary, application of
AMP-PNP, or ADP did not evoke any responses (−11 ± 1
pA for AMP-PNP, n = 6 cells; −13 ± 4 for ADP, n = 5 cells)
and the peak values analyzed as minimal peaks from the zero
baseline represent the negative portion of the noise in our
recordings (Figures 3A,B,D). Cells that were not responsive
to AMP-PNP or ADP were still responsive to hydrolysable
ATP (Figures 3A,B,D). We used higher concentrations of
ATP and AMP-PNP (up to 1mM) for electrophysiological
recordings to determine if saturating the P2RX2 receptor with
non-hydrolysable analog can open the channel. However, even
at higher concentrations, AMP-PNP failed to invoke inward
current responses. Further, we did not observe any current
responses from non-transfected cells following stimulation with
higher ATP concentrations ruling out the contribution of other
P2RX2 receptors at higher concentrations (Figures 3C,D). In
agreement with these results, we did not observe any current
responses from HEK 293 cells transfected with G353R P2RX2
stimulated with non-hydrolysable AMP-PNP or ADP (data not
shown). From these results, we concluded that ATP hydrolysis
plays a crucial role in opening the P2RX2 ion channels.
ATPase Activity of Cochlear
Neuroepithelium Expressing Endogenous
P2rx2
As P2rx2 plays an important role in the hair cell physiology
(Housley et al., 2002, 2013; Järlebark et al., 2002; Wang et al.,
2003), we examined ATP-evoked iP-release from postnatal day
3 rat cochlea organotypic culture hair cells that endogenously
express P2rx2 (Figure 4). The experiments performed without
explant cultures served as control group to rule out the non-
specific ATP hydrolysis. The ATPase activity of the developing
cochlear neuroepithelium endogenously expressing WT P2rx2
was significantly inhibited in the presence of P2rx2 competitive
antagonist RB-4, in a concentration-dependent manner (P <
0.01; Figure 4).
P2RX2 is a Classical ATPase and V60L
Mutation Hampers its Ability to Bind ATP
Next we determined whether P2RX2 is a classical ATPase
releasing ADP as a final product or ATP hydrolyzer with AMP
as a final product. To examine this, we incubated purified
protein with ATP and determined ADP or AMP release using
commercially available kits. We observed that P2RX2 is indeed
a classical ATPase that catalyzes the conversion of ATP into ADP
but not to AMP (Figure 5A).
It is possible that the inability of P2RX2 V60L to hydrolyze
ATP is due to the lack of ATP binding. To determine this,
we performed radioactive ATP filter binding assays for all four
purified forms of P2RX2. WT and G353R P2RX2 bound to
radioactive ATP proficiently whereas V60L and K81A P2RX2
forms showed significantly attenuated ATP binding activity (P <
0.001; Figure 5B). These results suggest that the V60L mutation
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FIGURE 2 | P2RX2 possesses ATPase activity. (A) ATP hydrolysis by purified P2RX2 protein was determined in the presence or absence of diverse cations by
BIOMOL green reagent. (B) In some experiments, P2RX2 specific competitive antagonist RB-4, was included in the reaction mixture. RB-4 was able to reduce the
ability of P2RX2 to hydrolyze ATP in a dose dependent manner. (C) The effect of mutations in P2RX2 was evaluated in the absence or presence of diverse cations. (D)
ATP hydrolysis was measured in live HEK293 cells expressing WT, V60L, and G353R P2RX2. (E) Michaelis-Menten kinetics equation was used to determine the Km
and Vm of P2RX2 ATPase activity. (F) Plot of ATP hydrolysis as a function of incubation time. The experiments were performed three different times in triplicate. Error
bars indicate standard deviations. *P < 0.01 by one-way ANOVA with post-hoc test.
hampers the ability of P2RX2 to bind ATP and hence abolishes
its ATPase activity.
Computer Modeling Suggests that P2RX2
V60L Mutation Affects the Conformation of
P2RX2 Leading to Altered ATP Binding and
Subsequent Hydrolysis
To understand the molecular basis of how V60L, K81A, and
G353R mutations affect the physiological function of the P2RX2
channel, we modeled its three-dimensional structure in both
closed and open states spanning residues 41–365. As presented
in Figure 6, our structural analysis shows that the P2RX2
channel adopts a canonical trimeric fold with a three-fold axis of
symmetry. V60L mutation can result in altered conformational
changes leading to inability of P2RX2 channel to bind ATP
and subsequently ATP hydrolysis. On the other hand, G353R
mutation does not have much impact on the ATP binding and
hydrolysis property of P2RX2 and would likely affect the intrinsic
properties of the pore ionic permeation.
DISCUSSION
P2RX receptors are purinergic ligand-gated trimeric ion channels
that are widely distributed in mammalian tissues, where they are
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FIGURE 3 | ATP hydrolysis plays a crucial role in gating of P2RX2
channel. (A–C) Current recording during application of a nonhydrolysable
analog of ATP (AMP-PNP) or ADP followed by the application of hydrolysable
ATP (red traces) performed in the same cell or in non-transfected (NT) cells.
(D) Summary bar graph of amplitudes during application of ATP, AMP-PNP,
and ADP in transfected and non-transfected cells.
FIGURE 4 | ATPase activity of organ of Corti explant cultures (A)
Cochlea explant cultures were established from 3 day old rats and
incubated with ATP. The hydrolysis of ATP was then examined using
BIOMOL green reagent. (B) ATPase activity of the cochlear organotypic
explant cultures expressing endogenous P2RX2 was determined in the
presence of different concentrations of P2RX2 specific competitive antagonist,
RB-4. The results are representative of three different experiments carried out
in triplicate. *P < 0.01 by one-way ANOVA with post-hoc test.
FIGURE 5 | ADP/AMP and radioactive ATP binding assays. (A) Purified
P2RX2 was incubated with ATP and release of ADP and AMP was determined
in the absence or presence of diverse cations using ELISA kits (Sigma). (B)
P2RX2 wild-type as well as mutant V60L, G353R, and K81A forms were
incubated with radioactive ATP, and their ATP binding capabilities were
determined using the filter binding assay as described in Materials and
Methods section. The results are representative of three different experiments
carried out in triplicate. Error bars indicate standard deviations. *P < 0.01 by
one-way ANOVA with post-hoc test.
involved in a range of processes, from inflammation to excitatory
synaptic transmission (Puchałowicz et al., 2014; Samways et al.,
2014; Xu and Khakh, 2014; Dal Ben et al., 2015; Di Virgilio, 2015).
It comprises a family of seven receptors designated P2RX1 to
P2RX7 (North, 2002). Out of these seven receptors, P2RX2 plays
an important role in auditory and nervous systems (Housley
et al., 2002, 2013; Järlebark et al., 2002; Wang et al., 2003; Mittal
et al., 2016). Earlier studies have demonstrated that mutations
in P2RX2, namely V60L and G353R, lead to hearing loss,
demonstrating the importance of this receptor in the inner ear
(Yan et al., 2013; Faletra et al., 2014).
The binding of ATP to P2RX2 has been shown to play an
important in gating the channel (Roberts et al., 2006). However,
it is still not known how P2RX2 acquires the energy required to
open the channel and perform its physiological function. In this
study, we demonstrate for the first time that P2RX2 is indeed
an ATPase that can degrade ATP, leading to the release of ADP
and free inorganic phosphate. We conducted these experiments
on solubilized purified P2RX2 protein that corroborates with
the findings of the earlier studies demonstrating ATPase activity
by purified proteins (Gresser et al., 1984; Liu et al., 1997;
Nikaido et al., 1997; Li and Altman, 2001; Andrade et al., 2007;
Yoshida et al., 2014). We found that P2RX2 is able to catalyze
the degradation of ATP in a linear, time dependent manner
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with a Km value of 0.62 mM. We also observed that it only
catalyzes the conversion of ATP to ADP and not further to AMP
indicating that P2rx2 is an ATPase and not ATP hydrolyzer.
Interestingly, V60L mutation abolished its ability to bind ATP
and subsequently ATP degradation. The inner ear organ of Corti
explant cultures from newborn rats also confirmed the presence
of a P2rx2-related ATPase activity.
Protein expression in live cells helps to examine
their physiological role in a membrane-associated native
conformation. Therefore, we used HEK293 live cells expressing
exogenous recombinant WT and mutant forms of P2RX2 and
determined their respective ATPase activity. In agreement with
the in vitro data obtained on purified proteins, we observed a
significant release of inorganic phosphate by cells expressing
WT or G353R form of P2RX2, but very little or no release
by V60L transfected and non-transfected cells, respectively.
The experiments were only performed on live HEK293 cells
and not on life mammalian neuroepithelia because of (i) the
non-availability of the appropriate animal models for each of the
studied mutations endogenously expressing mutant P2rx2, and
(ii) it is difficult to achieve a significantly high and reproducible
transfection and expression rates of the mutant proteins in
explant epithelium hair cells to allow the performance of similar
measurements. We are in the process of generating mouse
knock-in models for each of P2rx2 V60L and G353R mutations,
and their respective cochlea neuroepithelia will be used for
further investigating endogenous mutant P2rx2 ATPase activity.
The competitive antagonists or inhibitors are useful tools to
characterize the activity of target proteins and their specificity.
Therefore, we used P2RX2 specific inhibitor RB4, to confirm the
ATPase activity of P2RX2. RB-4 is a selective P2RX2 inhibitor
that exhibits no activity against other P2RX receptors (Baqi
et al., 2011). The ATPase activity of P2RX2 was significantly
decreased in the presence of RB-4 inhibitor demonstrating the
specificity of ATP degradation by P2RX2. Since we observed
significant decrease in ATPase activity with purified P2RX2
protein, it suggests that this activity is contributed only by P2RX2
and not by the other P2RX receptors. However, we observed
that EC50 value varies from few to 30 uM, whereas Km for
the ATP hydrolysis was about 700 uM. In other words, almost
complete channel’s activation occurred, when the occupancy of
sites, responsible for the ATP hydrolysis, could be low. It is
possible that since P2RX2 is a trimeric receptor, binding of few
ATP molecules and subsequent hydrolysis is sufficient to trigger
channel activation. Further studies are warranted to characterize
the relationship between EC50 and Km values for P2RX2.
The generation of inward current in response to ATP is
a reliable and well established parameter for monitoring the
gating of P2RX and other ion channels (Li et al., 2013; Yan
et al., 2013). Our electrophysiology data suggests that ATP
degradation is required for opening the P2RX2 channel as ATP
non-hydrolysable analog failed to evoke inward currents. It is
noteworthy that there are two non-hydrolyzable analogs of ATP,
ATPγS, and AMP-PNP. ATPγS has been shown to possess the
agonist activity and can activate numerous P2 receptors including
P2RX2 (Thomas et al., 1991; Evans et al., 1995). On the contrary,
AMP-PNP have been demonstrated to exert antagonist effect on
the ATPase activity of many ATPases (Gresser et al., 1984; Liu
et al., 1997; Li and Altman, 2001). Therefore, we used AMP-
PNP in this study and not ATPγS. Interestingly, AMP-PNP was
able to bind purified P2RX2 protein as determined by radioactive
filter binding assays (data not shown). This suggests that lack
of generation of inward currents in the presence of AMP-PNP
is not due its inefficient binding. It would also be possible that
ATP hydrolysis occurs after the channel is gated and entered a
secondary conformation. In this case, we should get some inward
currents with AMP-PNP. However, even by saturating the P2RX2
receptors with higher concentrations of AMP-PNP, we do not
observe any inward current responses. This data suggests that
ATPase activity plays a crucial role in the early stages of P2RX2
channel opening.
Computer modeling showed that P2RX2 is comprised of a six-
helical transmembrane bundle (with a pair of helices contributed
by each of the three monomers) hooked onto a predominantly
mixed αβ extracellular domain. This domain also harbors the
ATP-binding-pocket, in a manner akin to that observed for
the zebrafish P2RX4 channel (Kawate et al., 2009; Hattori
and Gouaux, 2012). Importantly, comparison of the closed
and open states reveals that ATP binding to the extracellular
domain is accompanied by a dramatic conformational change
within the P2RX2 channel. Though transmitted throughout
the channel, these extensive structural rearrangements are
particularly concentrated around the transmembrane pore
and the adjacent extracellular fenestrations. More specifically,
binding of ATP appears to be coupled to radial expansion (along
an axis parallel to the membrane surface) of the fenestrations
so as to facilitate the diffusion of extracellular cations into the
channel pore beneath.
How can we rationalize the functional effects observed in vitro
for the V60L, K81A and G353R mutations in the context of
opening and closing of the P2RX2 ion channel? Interestingly,
all three of these mutations map to key regions within the
channel. While the K81A mutation lines the ATP-binding pocket
within the extracellular domain, the V60L and G353R changes
are located within the transmembrane helices. Given that V60
residue is located within the transmembrane pore, close to its
extracellular opening, we believe that it plays a key role in relaying
and transducing the mechanical movement of the fenestrations
into the pulling action exerted on the transmembrane helices
so as to release the mechanical energy. While V60L mutation
alone may not appear damaging, it is nonetheless likely to alter
the dynamics of the whole system, albeit in a subtle manner.
Importantly, the triple effect of the V60L mutation due to its
presence within each of the three monomers will be expected
to be highly cooperative and such synergism could indeed
substantially affect the transfer of movement from the expansion
of the upstream fenestrations to the opening of the downstream
channel pore. Thus, failure to couple such mechanical signal
would have a reciprocating effect in that it would resist the
fenestrations from undergoing expansion. The subsequent lack of
ensuing flexibility and the sustained rigidity of the extracellular
domain would in turn be expected to directly affect the
formation of the ATP-binding pocket and hence the binding of
ATP itself.
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FIGURE 6 | Ribbon representation of the structural model of human P2RX2 ion channel in the closed and open states. In each case, two alternative
orientations of the P2RX2 channel related by a 90◦-clockwise rotation about the horizontal axis are displayed. Within each orientation, the homotrimeric P2RX2
channel is color-coded with the three monomers shown in yellow, blue, and green. Additionally, the side chain moieties of V60 and G353 residues located within the
transmembrane helices and K81 within the extracellular domain are all shown in red. The numerals 41 and 365 respectively indicate the N-terminal and C-terminal
residue boundaries of the modeled region of P2RX2 channel and the parenthesized letters following these numerals represent each of the three monomers. The arrow
traversing the ion channel in the open state denotes the route of the influx of cations such as Na+ upon channel opening. Residue atoms for V60, K81, and G353 are
highlighted as gray spheres. The three ATP molecules are shown as sticks.
While glycine residues tend to destabilize helices in water-
soluble proteins, they play a fundamental role in the formation of
transmembrane helices (Javadpour et al., 1999; Dong et al., 2012).
In particular, glycines induce kinks in transmembrane helices
(Video S1) that allow their tight packing and, consequently,
promote transmembrane association and oligomerization of
polytopic membrane proteins. In light of this knowledge,
the G353 residue is thus critical to the intermittent closing
and opening of the P2RX2 channel in response to ATP
binding. Accordingly, the G353R mutation would be expected
to disrupt the native packing of transmembrane helices, thereby
resulting in the disruption of ion flow across the P2RX2
channel in remarkable agreement with our in vitro data. In
summary, our structural analysis of the P2RX2 channel provides
an exquisite peek into its dynamics and corroborates our
in vitro data.
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To our knowledge, this is the first study to demonstrate
the ATPase activity of P2X2 ion channel. Future investigations
will aim to determine key residues that are directly involved in
the ATPase catalytic site of the channel, and to exploit these
structural and functional insights toward the rational design of
novel activators and inhibitors of the P2RX2 channel.
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